GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » EV-to-EBIT

Moss Genomics (XCNQ:MOSS) EV-to-EBIT : -4.08 (As of Jun. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Moss Genomics's Enterprise Value is C$0.87 Mil. Moss Genomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.21 Mil. Therefore, Moss Genomics's EV-to-EBIT for today is -4.08.

The historical rank and industry rank for Moss Genomics's EV-to-EBIT or its related term are showing as below:

XCNQ:MOSS' s EV-to-EBIT Range Over the Past 10 Years
Min: -79.2   Med: 0   Max: 0
Current: -4.08

XCNQ:MOSS's EV-to-EBIT is ranked worse than
100% of 431 companies
in the Healthcare Providers & Services industry
Industry Median: 17.06 vs XCNQ:MOSS: -4.08

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Moss Genomics's Enterprise Value for the quarter that ended in Mar. 2024 was C$0.87 Mil. Moss Genomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.21 Mil. Moss Genomics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -24.50%.


Moss Genomics EV-to-EBIT Historical Data

The historical data trend for Moss Genomics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics EV-to-EBIT Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
EV-to-EBIT
- -6.68

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.98 -6.68 -6.46 -6.03 -4.08

Competitive Comparison of Moss Genomics's EV-to-EBIT

For the Health Information Services subindustry, Moss Genomics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moss Genomics's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Moss Genomics's EV-to-EBIT falls into.



Moss Genomics EV-to-EBIT Calculation

Moss Genomics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.874/-0.214
=-4.08

Moss Genomics's current Enterprise Value is C$0.87 Mil.
Moss Genomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moss Genomics  (XCNQ:MOSS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Moss Genomics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-0.214/0.87354
=-24.50 %

Moss Genomics's Enterprise Value for the quarter that ended in Mar. 2024 was C$0.87 Mil.
Moss Genomics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moss Genomics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Moss Genomics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics (XCNQ:MOSS) Business Description

Traded in Other Exchanges
N/A
Address
1030 West Georgia Street, Suite 907, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that offers personalized health, antiaging and wellness offerings guided by genomic, microbiome, and epigenome data. The Company intends to eliminate barriers in healthcare by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.

Moss Genomics (XCNQ:MOSS) Headlines

No Headlines